{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:20:59Z","timestamp":1788452459031,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Somatostatin and its analogues, which function by binding to somatostatin receptors (SSTRs) 1\u20135, play a protective role in liver cirrhosis. Hepatic SSTR-2 expression is up-regulated in subjects with liver cirrhosis. However, little is known about the mechanisms underlying this process. In the present study, we observed the up-regulation of hepatic SSTR-2 expression in thioacetamide (TAA)-induced cirrhotic rats and further showed that cyclooxygenase-2 (COX-2) might play a role in this process via the protein kinase C (PKC)\u2013cAMP response element binding protein (CREB) signaling pathway. <jats:italic>In vivo<\/jats:italic>, the up-regulated SSTR-2 in liver cirrhosis was inhibited by the addition of a selective COX-2 inhibitor, such as celecoxib. <jats:italic>In vitro<\/jats:italic>, the up-regulation of COX-2 by either transfection with COX-2 plasmids or treatment with TAA increased levels of SSTR-2 and phosphorylated CREB (p-CREB) in the human hepatocyte cell line L02. Furthermore, the increase in SSTR-2 expression was inhibited by the addition of celecoxib and a PKC inhibitor. Moreover, for comparable DNA methylation levels in the region upstream of the hepatic SSTR-2 gene in normal and cirrhotic livers, DNA methylation may not contribute to the up-regulation of SSTR-2 expression in cirrhotic livers. In conclusion, the up-regulation of hepatic SSTR-2 might be induced by COX-2 via the PKC-CREB signaling pathway but is probably not induced by DNA methylation.<\/jats:p>","DOI":"10.1038\/s41598-018-29349-y","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T09:14:10Z","timestamp":1531818850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression"],"prefix":"10.1038","volume":"8","author":[{"given":"Yao-Yao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"29349_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nrd1255","volume":"2","author":"G Weckbecker","year":"2003","unstructured":"Weckbecker, G. et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2, 999\u20131017 (2003).","journal-title":"Nat Rev Drug Discov"},{"key":"29349_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/gutjnl-2015-310928","volume":"66","author":"S Sundaresan","year":"2017","unstructured":"Sundaresan, S., Kang, A. J., Hayes, M. M., Choi, E. K. & Merchant, J. L. Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids. Gut 66, 1012\u20131021 (2017).","journal-title":"Gut"},{"key":"29349_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10456-016-9522-9","volume":"19","author":"JH Gao","year":"2016","unstructured":"Gao, J. H. et al. Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis 19, 501\u2013511 (2016).","journal-title":"Angiogenesis"},{"key":"29349_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1053\/gast.2001.27971","volume":"121","author":"H Reynaert","year":"2001","unstructured":"Reynaert, H. et al. Somatostatin suppresses endothelin-1\u2013induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 121, 915\u2013930 (2001).","journal-title":"Gastroenterology"},{"key":"29349_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/sj.bjp.0706298","volume":"146","author":"H Reynaert","year":"2005","unstructured":"Reynaert, H. et al. Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol 146, 77\u201388 (2005).","journal-title":"Br J Pharmacol"},{"key":"29349_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3892\/mmr.2014.2735","volume":"11","author":"SB Guo","year":"2015","unstructured":"Guo, S. B. et al. Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression. Mol Med Rep 11, 83\u201390 (2015).","journal-title":"Mol Med Rep"},{"key":"29349_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2036.2003.01657.x","volume":"18","author":"H Reynaert","year":"2003","unstructured":"Reynaert, H. & Geerts, A. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Alimentary Pharmacology and Therapeutics 18, 375\u2013386 (2003).","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"29349_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1478-3231.2007.01629.x","volume":"28","author":"E Vanheule","year":"2008","unstructured":"Vanheule, E. et al. Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver Int 28, 107\u2013116 (2008).","journal-title":"Liver Int"},{"key":"29349_CR9","doi-asserted-by":"crossref","unstructured":"Rhaiem, R. et al. Portal Inflow Modulation by Somatostatin After Major Liver Resection: A Pilot Study. Ann Surg (2017).","DOI":"10.1097\/SLA.0000000000002601"},{"key":"29349_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/gut.2003.036053","volume":"53","author":"H Reynaert","year":"2004","unstructured":"Reynaert, H. et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 53, 1180\u20131189 (2004).","journal-title":"Gut"},{"key":"29349_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23957-4","volume":"8","author":"MN Leseva","year":"2018","unstructured":"Leseva, M. N. et al. Differences in DNA Methylation and Functional Expression in Lactase Persistent and Non-persistent Individuals. Sci Rep 8, 5649 (2018).","journal-title":"Sci Rep"},{"key":"29349_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","volume":"31","author":"RJ Klose","year":"2006","unstructured":"Klose, R. J. & Bird, A. P. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31, 89\u201397 (2006).","journal-title":"Trends Biochem Sci"},{"key":"29349_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton, A. M. & Bird, A. CpG islands and the regulation of transcription. Genes Dev 25, 1010\u20131022 (2011).","journal-title":"Genes Dev"},{"key":"29349_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15634-9","volume":"7","author":"A Finegersh","year":"2017","unstructured":"Finegersh, A. et al. DNA methylation regulates TMEM16A\/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma. Sci Rep 7, 15173 (2017).","journal-title":"Sci Rep"},{"key":"29349_CR15","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1210\/en.2007-1525","volume":"149","author":"J Torrisani","year":"2008","unstructured":"Torrisani, J. et al. Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modifications. Endocrinology 149, 3137\u20133147 (2008).","journal-title":"Endocrinology"},{"key":"29349_CR16","first-page":"151","volume":"20","author":"Z Liu","year":"2008","unstructured":"Liu, Z., Marquez, M., Nilsson, S. & Holmberg, A. R. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. Oncology Reports 20, 151\u2013154 (2008).","journal-title":"Oncology Reports"},{"key":"29349_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/07357907.2014.1001892","volume":"33","author":"MM Tiscornia","year":"2015","unstructured":"Tiscornia, M. M., Gonzalez, H. S., Lorenzati, M. A. & Zapata, P. D. Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development. Cancer Invest 33, 61\u201369 (2015).","journal-title":"Cancer Invest"},{"key":"29349_CR18","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1210\/jc.2004-0271","volume":"89","author":"D Seboek","year":"2004","unstructured":"Seboek, D. et al. Somatostatin is expressed and secreted by human adipose tissue upon infection and inflammation. J Clin Endocrinol Metab 89, 4833\u20134839 (2004).","journal-title":"J Clin Endocrinol Metab"},{"key":"29349_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1365-2982.2007.00931.x","volume":"19","author":"VO den Bosch","year":"2007","unstructured":"den Bosch, V. O. et al. J. P. Effect of intestinal inflammation on the cell-specific expression of somatostatin receptor subtypes in the murine ileum. Neurogastroenterol Motil 19, 596\u2013606 (2007).","journal-title":"Neurogastroenterol Motil"},{"key":"29349_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1369\/jhc.2008.950998","volume":"56","author":"S Bhandari","year":"2008","unstructured":"Bhandari, S. et al. Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney. J Histochem Cytochem 56, 733\u2013743 (2008).","journal-title":"J Histochem Cytochem"},{"key":"29349_CR21","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1210\/en.2008-0577","volume":"150","author":"I Minsel","year":"2009","unstructured":"Minsel, I. et al. Somatostatin actions via somatostatin receptors on the ocular surface are modulated by inflammatory processes. Endocrinology 150, 2254\u20132263 (2009).","journal-title":"Endocrinology"},{"key":"29349_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith, W. L. & Garavito, D. D. RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145\u2013182 (2000).","journal-title":"Annu Rev Biochem"},{"key":"29349_CR23","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1111\/jgh.12641","volume":"29","author":"S-L Wen","year":"2014","unstructured":"Wen, S.-L. et al. Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. Journal of Gastroenterology and Hepatology 29, 1932\u20131942 (2014).","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"29349_CR24","doi-asserted-by":"publisher","first-page":"G962","DOI":"10.1152\/ajpgi.00428.2015","volume":"310","author":"JH Gao","year":"2016","unstructured":"Gao, J. H. et al. Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats. Am J Physiol Gastrointest Liver Physiol 310, G962\u2013972 (2016).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"29349_CR25","doi-asserted-by":"publisher","first-page":"e69309","DOI":"10.1371\/journal.pone.0069309","volume":"8","author":"JH Gao","year":"2013","unstructured":"Gao, J. H. et al. Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. PLoS One 8, e69309 (2013).","journal-title":"PLoS One"},{"key":"29349_CR26","first-page":"710","volume":"46","author":"YM Xie","year":"2015","unstructured":"Xie, Y. M. et al. The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 46, 710\u2013716 (2015).","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"29349_CR27","first-page":"137","volume":"50","author":"U Kumar","year":"2010","unstructured":"Kumar, U. & Grant, M. Samatostatin and Somatostatin Receptors. Results Probl Cell Differ 50, 137\u2013184 (2010).","journal-title":"Results Probl Cell Differ"},{"key":"29349_CR28","doi-asserted-by":"publisher","first-page":"9425","DOI":"10.18632\/oncotarget.2444","volume":"5","author":"RA Hlady","year":"2014","unstructured":"Hlady, R. A. et al. Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis. Oncotarget 5, 9425\u20139443 (2014).","journal-title":"Oncotarget"},{"key":"29349_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/ijc.26136","volume":"130","author":"O Ammerpohl","year":"2012","unstructured":"Ammerpohl, O. et al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 130, 1319\u20131328 (2012).","journal-title":"Int J Cancer"},{"key":"29349_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-5-5","volume":"5","author":"Y Komatsu","year":"2012","unstructured":"Komatsu, Y. et al. Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med Genomics 5, 5 (2012).","journal-title":"BMC Med Genomics"},{"key":"29349_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0056-6","volume":"7","author":"M Zeybel","year":"2015","unstructured":"Zeybel, M. et al. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clin Epigenetics 7, 25 (2015).","journal-title":"Clin Epigenetics"},{"key":"29349_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JME-07-0108","volume":"40","author":"N Kimura","year":"2008","unstructured":"Kimura, N., Takamatsu, N., Yaoita, Y., Osamura, R. Y. & Kimura, N. Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation. J Mol Endocrinol 40, 75\u201391 (2008).","journal-title":"J Mol Endocrinol"},{"key":"29349_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4143\/crt.2011.43.3.181","volume":"43","author":"HS Kim","year":"2011","unstructured":"Kim, H. S., Lee, H. S. & Kim, W. H. Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors. Cancer Res Treat 43, 181\u2013188 (2011).","journal-title":"Cancer Res Treat"},{"key":"29349_CR34","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0016-5085(03)00904-1","volume":"125","author":"H Yamamoto","year":"2003","unstructured":"Yamamoto, H. et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. The authors thank Y. Naito and S. Yamane for preparation of numerous paraffin sections; S. Hayashi, I. Seshimo, H. Ota, and S. Yamamoto for staining and pathologic works; and K. Goto and M. Kubota for animal experiments. Gastroenterology 125, 556\u2013571 (2003).","journal-title":"Gastroenterology"},{"key":"29349_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1006\/bbrc.1993.1412","volume":"192","author":"YC Patel","year":"1993","unstructured":"Patel, Y. C. & Kent, G. M. G. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regualtion. Biochemical and biophysical research communications 192, 288\u2013294 (1993).","journal-title":"Biochemical and biophysical research communications"},{"key":"29349_CR36","first-page":"160726","volume":"2012","author":"S Li","year":"2012","unstructured":"Li, S. et al. Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling. Evid Based Complement Alternat Med 2012, 160726 (2012).","journal-title":"Evid Based Complement Alternat Med"},{"key":"29349_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.intimp.2015.02.012","volume":"25","author":"Q Wang","year":"2015","unstructured":"Wang, Q. et al. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP\/PKA\/CREB pathway in rat hepatic stellate cells. Int Immunopharmacol 25, 340\u2013352 (2015).","journal-title":"Int Immunopharmacol"},{"key":"29349_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cca.2010.12.026","volume":"412","author":"MT Rizzo","year":"2011","unstructured":"Rizzo, M. T. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta 412, 671\u2013687 (2011).","journal-title":"Clin Chim Acta"},{"key":"29349_CR39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.2174\/138161211796196936","volume":"17","author":"J Li","year":"2011","unstructured":"Li, J. & Tang, W. R. C. Somatostatin and octreotide on the treatment of acute pancreatitis - basic and clinical studies for three decades. Curr Pharm Des 17, 1594\u20131601 (2011).","journal-title":"Curr Pharm Des"},{"key":"29349_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MPA.0000000000000090","volume":"43","author":"S Sethi","year":"2014","unstructured":"Sethi, S., Wadhwa, S. N., Garud, V. & Brown, S. A. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas 43, 190\u2013197 (2014).","journal-title":"Pancreas"},{"key":"29349_CR41","first-page":"17551","volume":"8","author":"O Ozer Cakir","year":"2015","unstructured":"Ozer Cakir, O., Toker, E. H., Ataseven, A., Demir, H. & Polat, A. H. Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice. Int J Clin Exp Med 8, 17551\u201317564 (2015).","journal-title":"Int J Clin Exp Med"},{"key":"29349_CR42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4161\/cbt.12.1.15730","volume":"12","author":"Y Xie","year":"2011","unstructured":"Xie, Y., Chen, S., Wang, C. H. & Tang, C. W. SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts. Cancer Biol Ther 12, 86\u201392 (2011).","journal-title":"Cancer Biol Ther"},{"key":"29349_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/138955707780859431","volume":"7","author":"FH Sarkar","year":"2007","unstructured":"Sarkar, F. H., Adsule, S., Li, Y. & Padhye, S. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev Med Chem 7, 599\u2013608 (2007).","journal-title":"Mini Rev Med Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29349-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:50:01Z","timestamp":1671609001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29349-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29349"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29349-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11033"}}